ALTO-100 study for adults with major depression
About this title
Read the official source — NCT05712187Researchers compared ALTO-100 and placebo to find out how the approaches affected depression symptoms in adults with depression.
Understand this study
What did researchers investigate?
Researchers compared ALTO-100 and placebo to find out how the approaches affected depression symptoms in adults with depression.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 64 years. Other eligibility criteria applied.
- Listed locations
- Birmingham and 33 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 301
- Sponsor
- Alto Neuroscience
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT05712187
- Official title
Show the full official title
A Randomized, Double-Blind, Placebo-Controlled Study of ALTO-100 With an Open-Label Extension in Adults With Major Depressive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Birmingham · Huntsville · Chandler
26 more locations
- Little Rock
- Costa Mesa
- Fresno
- Imperial
- Oceanside
- Rancho Cucamonga
- Sacramento
- Centennial
- Brooksville
- Jacksonville
- Orlando
- Tampa
- Carmel
- Baltimore
- Jackson
- Lincoln
- Las Vegas
- Albuquerque
- Brooklyn
- New York
- Westlake
- North Charleston
- Memphis
- Fort Worth
- Houston
- Draper
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared ALTO-100 and placebo to find out how the approaches affected depression symptoms in adults with depression.
Who is behind this study?
The study sponsor is Alto Neuroscience.
Did this study involve medication?
Yes. The study involved medication, including ALTO-100 and Placebo.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 64 years. Other eligibility criteria applied.
